Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

Vitamin D supplementation Respiratory Distress Syndrome 0303 health sciences Immune cytotoxic response SARS-CoV-2 Immunity COVID-19 Vitamins Article COVID-19 Drug Treatment 3. Good health 03 medical and health sciences Dietary Supplements Humans Single-Blind Method Prospective Studies Vitamin D Cholecalciferol
DOI: 10.1016/j.biopha.2022.112965 Publication Date: 2022-04-14T07:13:33Z
ABSTRACT
Main cause of severe illness and death in COVID-19 patients appears to be an excessive but ineffectual inflammatory immune response that may acute respiratory distress syndrome (ARDS). Vitamin D favour anti-inflammatory environment improve cytotoxic against some infectious diseases. A multicenter, single-blind, prospective, randomized clinical trial was approved with pneumonia levels 25-hydroxyvitamin (25(OH)D) 14.8 ng/ml (SD: 6.18) test antiviral efficacy, tolerance safety 10,000 IU/day cholecalciferol (vitamin
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (63)
CITATIONS (32)